The global guidewire market is projected to reach USD 764.0 Million by 2022 from USD 582.5 Million in 2016, at a CAGR of 4.8%.

Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=8118028

Top Key Players 
In 2016, Boston Scientific (US), Abbott Laboratories (US), Medtronic (Ireland), Terumo Corporation (Japan), and Cook Group (US) held the leading position in the global guidewires market. In the past three years, these companies adopted product developments & commercialization, acquisitions, market expansions, and agreements & collaborations as their key business strategies to ensure market dominance. 

Cardinal Health (US), Olympus (Japan), Johnson & Johnson (US), B. Braun (Germany), and C.R. Bard (US) are some of the other major players in this market.

The growth witnessed by guidewires is mainly driven by the growing target patient population, continuous product launches by major manufacturers, increasing availability of medical reimbursements for guidewires across developed countries, and rising adoption of minimally invasive surgical procedures across major countries.

Browse 66 tables and 39 figures spread through 156 pages and in-depth TOC on "Guidewires Market"
Factors such as high cost of surgical guidewires, spending cuts, and excise duties on medical devices and dearth of skilled surgeons for minimally invasive surgeries are expected to restrain the growth of the market during the forecast period.

This report covers the market across four major regions. North America is expected to command the largest share of the market in 2017. Factors such as increasing availability of reimbursements for guidewires among developed countries, increasing patient preference for minimally invasive surgical procedures (including atherectomy, thrombectomy, embolectomy, and gastrointestinal endoscopy), and strong market presence of key OEMs (that replicates into easy availability of guidewires) are driving the growth of the North American guidewires market.

About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC. 
630 Dundee Road 
Suite 430 
Northbrook, IL 60062 
USA : 1–888–600–6441 
[email protected]